New medications targeting triglyceride-rich lipoproteins: Can inhibition of ANGPTL3 or apoC-III reduce the residual cardiovascular risk?
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Juha Sinisalo Matti Jauhiainen |
| Publication date | May 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |